| Mrs Jacqueline B Jordan, CCC-SLP | |
|
358 Mclaws Cir, Suite 1, Williamsburg, VA 23185-6344 | |
| (757) 645-3339 | |
| (757) 645-4830 |
| Full Name | Mrs Jacqueline B Jordan |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 358 Mclaws Cir, Williamsburg, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023373644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2202000636 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jacqueline B Jordan, CCC-SLP 358 Mclaws Cir, Suite 1, Williamsburg, VA 23185-6344 Ph: (757) 645-3339 | Mrs Jacqueline B Jordan, CCC-SLP 358 Mclaws Cir, Suite 1, Williamsburg, VA 23185-6344 Ph: (757) 645-3339 |
News Archive
Psychotic spectrum (PS) disorders are characterized by abnormalities in beliefs, perceptions and behavior, but how these disorders manifest themselves in earlier development stages is largely unknown.
A discovery made by Dr. Tarik Möröy, President and Scientific Director and Director of the IRCM, and his team was recently published in Blood, the official journal of the American Society of Hematology. The researchers found that a protein can regulate certain characteristics of blood stem cells, which could lead to a better treatment for leukemia patients.
A US national survey reports that even children who have had cancer previously, and are therefore at increased risk of developing further cancers, are not receiving vaccination against human papillomavirus (HPV).
A team of young researchers at the National University of Science and Technology has recently presented its new development – therapeutic material based on nanofibers of polycaprolactone, modified with plasma-deposited thin layers enriched with antibacterial composition and human blood plasma components.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that various studies on ZEVALIN for Injection were presented at the 11th International Conference on Malignant Lymphoma (ICML), held June 15-18, 2011, in Lugano, Switzerland.
› Verified 8 days ago
Williamsburg Speech Specialties, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1769 Jamestown Rd, Suite 103, Williamsburg, VA 23185 Phone: 757-229-2516 Fax: 757-565-1738 | |
Katherine Mills, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 203 Bulifants Blvd, Williamsburg, VA 23188 Phone: 571-239-6324 | |
Sarah Tschirhart, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1235 S Mount Vernon Ave, Williamsburg, VA 23185 Phone: 757-208-7110 | |
Alaina Lamarco, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 457 Mclaws Cir, Williamsburg, VA 23185 Phone: 757-271-4447 | |
Miss Britney Spells, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 440 Mclaws Cir, Williamsburg, VA 23185 Phone: 757-903-4139 | |
Stephanie Marie Brockler Robinson, M.S., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4132 Longhill Rd, Williamsburg, VA 23188 Phone: 757-645-4620 |